Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1 1

Status

Completed 51Unknown 22Recruiting 15Terminated 9Withdrawn 7Active not recruiting 7Not yet recruiting 4Available 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 10Tumor-Agnostic 7Thoracic 4Genitourinary 3Sarcoma 2Plasma cell 1Breast 1

Conditions

Neoplasms 112Neoplasm Metastasis 24Carcinoma, Squamous Cell 9Adenocarcinoma 7Carcinoma 5Neoplasms, Unknown Primary 2Neoplasms, Second Primary 2Neoplasms by Site 1Neoplasm, Residual 1

Interventions

nimotuzumab 1devimistat 1bemarituzumab 1belinostat 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Nivolumab 1Ipilimumab 1Interviews as Topic 1Heavy Ion Radiotherapy 1Gemcitabine 1Cisplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Withdrawn × Adenocarcinoma × Tumor-Agnostic × Clear all
NCT06967987 2026-01-21

BEMAFLOT

Institut Cancerologie de l'Ouest

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma

NCT03536182 2021-05-26

CIPHER

University of Texas Southwestern Medical Center

Phase 3 Withdrawn
Tumor-Agnostic

Adenocarcinoma

NCT00247936 2021-01-26

Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.

University of California, Irvine

Phase NA Withdrawn
Tumor-Agnostic

Adenocarcinoma

NCT04315155 2020-10-28

BENEFIT

University of Utah

Phase 1 Withdrawn
Tumor-Agnostic

Adenocarcinoma

NCT01148082 2017-06-26

School Response to Families Who Have Children With Cancer

Stanford University

Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell

NCT01301612 2014-07-14

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Eurofarma Laboratorios S.A.

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma

NCT01830322 2013-08-14

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer

Cornerstone Pharmaceuticals

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡